Aidalos develops cognitive AI agents that combine analysis, reasoning and decision-support designed for tasks where traceability, quality assurance and transparency are critical. The company positions its solutions for use in infrastructure, industry, medicine and health, and has highlighted projects and collaborations with partners such as IBM as well as presentations at MIT. Aidalos plans to use the new capital to expand in the U.S., strengthen sales and commercialization, and build larger technical teams in Trondheim and Oslo. DNV cited the company’s focus on explainability and trust as key for applications in infrastructure, energy and risk management. The firm attracted a diverse investor base in the recent raise, signaling cross-industry interest. The company completed a NOK 15.5 million capital round, exceeding its NOK 10 million minimum target.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2026